EcoDrugPlus

Ensembl ID : ENSTNIG00000017657
Gene Symbol: PDGFRA
2 Cross references
204 Possible Orthologues:

Ensembl ID : ENSTNIG00000017961
Gene Symbol: -
2 Cross references
258 Possible Orthologues:

Ensembl ID : ENSTNIG00000018193
Gene Symbol: -
1 Cross references
214 Possible Orthologues:

Ensembl ID : ENSTNIG00000018446
Gene Symbol: RXRBB
2 Cross references
211 Possible Orthologues:

Ensembl ID : ENSTNIG00000018469
Gene Symbol: PSENEN
2 Cross references
183 Possible Orthologues:

Ensembl ID : ENSTNIG00000018650
Gene Symbol: YES1
2 Cross references
206 Possible Orthologues:

Ensembl ID : ENSTNIG00000018835
Gene Symbol: -
1 Cross references
190 Possible Orthologues:

Ensembl ID : ENSTNIG00000018846
Gene Symbol: RPL34
2 Cross references
362 Possible Orthologues:

Ensembl ID : ENSTNIG00000019467
Gene Symbol: RPS21
2 Cross references
287 Possible Orthologues:

Ensembl ID : ENSTNIG00000019527
Gene Symbol: SRC
2 Cross references
197 Possible Orthologues:

Ensembl ID : ENSTNIG00000019574
Gene Symbol: -
1 Cross references
122 Possible Orthologues:

Ensembl ID : ENSTNIG00000019622
Gene Symbol: -
1 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).